IP Verse

Combination Therapy With A Hyaluronan Degrading Enzyme And An Immune Checkpoint Inhibitor - EP3186281

PATENT ANALYSIS

Patent Details

Grant Date
Apr 10, 2019
Company
HALOZYME, INC.
Oppositions

J A KEMP LLP

More patents of Halozyme, Inc.

EP3760715

EP3186281

Want to monitor this patent?

Feel free to send us a message here and we will get back to you